Was gibt es Neues zur Gicht?

Berichte vom ACR 2018

What is new on gout?

Report from ACR 2018

This is a preview of subscription content, access via your institution.

Literatur

  1. 1.

    Kiltz U, Perez-Ruiz F, Uhlig T et al (2018) The prevalence and incidence of gout, its associated comorbidities and treatment pattern: An epidemiological study from Germany. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1131)

    Google Scholar 

  2. 2.

    Zhu Y, Pandya BJ, Choi HK (2010) Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63(10):3136–3141

    Article  Google Scholar 

  3. 3.

    Chen-Xu M, Yokose C, Pillinger M, Choi HK (2018) Contemporary prevalence of gout and hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015–2016) and decadal trends (NHANES 2007–2016). 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1149)

    Google Scholar 

  4. 4.

    Chen-Xu M, Yokose C, Pillinger M, Choi HK (2018) Prevalence of urate-lowering therapy use and target urate level achievement among gout patients in the United States (National Health And Nutrition Examination Survey [NHANES] 2007–2014). 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2237)

    Google Scholar 

  5. 5.

    Chen-Xu M, Yokose C, Pillinger M, Choi HK (2018) Contemporary comorbidity burden of gout and hyperuricemia in the US during the past decade (National Health And Nutrition Examination Survey [NHANES] 2007–2016). 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2236)

    Google Scholar 

  6. 6.

    Khanna PP, Taylor DCA, Fu AC, Morlock R (2018) Patient-reported burden of gout in 2017 from the United States. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 870)

    Google Scholar 

  7. 7.

    Khanna PP, Taylor DCA, Fu AC et al (2018) What did patients from the US think about their gout in 2017? 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1273)

    Google Scholar 

  8. 8.

    Singh JA, Cleveland J (2018) Gout and chronic pain in older adults: A medicare claims study. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1126)

    Google Scholar 

  9. 9.

    Murugesan V, Tran J (2018) Epidemiological characteristics of inpatient admissions for acute inflammatory gout arthropathy and factors affecting length of stay: A national level study. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1124)

    Google Scholar 

  10. 10.

    Singh G, Mithal A (2018) Not just a swollen big toe: Increasing all-cause hospitalizations in patients with gout in the United States: 1993–2014. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2249)

    Google Scholar 

  11. 11.

    Taylor DCA, Jaffe D, Hoshen M et al (2018) Is the serum uric acid therapeutic target protective of chronic kidney disease, cardiovascular disease, and mortality for patients with gout? A longitudinal study. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 872)

    Google Scholar 

  12. 12.

    Proudman C, Lester S, Gonzalez-Chica D et al (2018) Gout, flares and allopurinol use: A population based study. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2220)

    Google Scholar 

  13. 13.

    Kuo CF, Grainge MJ, Mallen C et al (2015) Rising burden of gout in the UK but continuing suboptimal management: A nationwide population study. Ann Rheum Dis 74(4):661–667

    Article  Google Scholar 

  14. 14.

    Panginikkod S, Raja A, Rajabirostami E et al (2018) A survey on gout-related knowledge among internal medicine residents. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 194)

    Google Scholar 

  15. 15.

    Kiltz U, Smolen J, Bardin T et al (2017) Treat-to-target (T2T) recommendations for gout. Ann Rheum Dis 76(4):632–638

    Article  CAS  Google Scholar 

  16. 16.

    White WB, Saag KG, Becker MA et al (2018) Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med 378:1200–1210

    Article  CAS  Google Scholar 

  17. 17.

    Saag K, Becker MA, White WB et al (2018) General safety of febuxostat and allopurinol in a cardiovascular outcomes study in patients with gout. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 873)

    Google Scholar 

  18. 18.

    Quilis N, Ranieri L, Sanchez-Paya J, Andrés M (2018) New cardiovascular events in patients with gout treated with xanthine-oxidase inhibitors: An inception cohort analysis. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. L01)

    Google Scholar 

  19. 19.

    Perez-Ruiz F, Richette P, Stack A et al (2018) Failure to reach serum urate target is associated with elevated mortality in gout. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 869)

    Google Scholar 

  20. 20.

    Rai SK, Lu N, Yokose C et al (2018) Preventing a large majority of incident gout cases by modifying key risk factors: Findings from a prospective cohort of 44,629 men over 26 years. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 874)

    Google Scholar 

  21. 21.

    DiFiore M, Wong M, Chang J (2018) Diet modification for gout patients: Effects on gout attacks and risk factors for metabolic syndrome. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1132)

    Google Scholar 

  22. 22.

    Gamala M, Jacobs JWG, Linn-Rasker S et al (2018) Dual-energy CT for the diagnosis of gout: A prospective study in patients with no prior history of gout. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1275)

    Google Scholar 

  23. 23.

    Yokose C, Zhang Y, Dalbeth N et al (2018) Patterns of monosodium urate deposition on dual-energy CT in gout patients on urate-lowering therapy. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 866)

    Google Scholar 

  24. 24.

    Yokose C, Dalbeth N, Nicolaou S et al (2018) Monosodium urate deposition distribution in the knees, hands, and feet of treated gout patients: A dual-energy CT study. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2235)

    Google Scholar 

  25. 25.

    Lautour H, Taylor WJ, Adebajo A et al (2016) Development of preliminary de remission criteria for gout using Delphi and 1000Minds consensus exercises. Arthritis Care Res (Hoboken) 68(5):667–672

    Article  Google Scholar 

  26. 26.

    Dalbeth N, Frampton C, Fung M et al (2018) Construct validity of provisional remission criteria for gout: A dual energy CT study. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2222)

    Google Scholar 

  27. 27.

    Yokose C, Zhang Y, Dalbeth N et al (2018) A prospective study examining the prevalence of CT erosions in the feet and ankles of patients with gout treated with allopurinol. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1277)

    Google Scholar 

  28. 28.

    Dalbeth N, Billington K, Doyle A et al (2018) Allopurinol dose escalation slows progression of CT bone erosion in people with gout: Imaging sub-study of a randomized control trial. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2969)

    Google Scholar 

  29. 29.

    Azeem R, Sands E, Johnston L et al (2018) Initial phase 2 clinical data of SEL-212 in symptomatic gout patients: Measurement of dissolution of urate deposits associated with monthly dosing of a pegylated uricase (pegadricase) with Svp-rapamycin by dual energy computed tomography. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 2205)

    Google Scholar 

  30. 30.

    Saag K, Feinman M, Baraf HSB et al (2018) Initial pegloticase serum levels predict persistent responsiveness in patients with chronic refractory gout. 2018 ACR/ARHP Annual Meeting, Chicago, 19.–24.10.2018 (abstract nr. 1284)

    Google Scholar 

  31. 31.

    Calabrese LH, Kavanaugh A, Yeo AE, Lipsky PE (2017) Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout. Arthritis Res Ther 19(1):191

    Article  CAS  Google Scholar 

  32. 32.

    Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29–42

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to PD Dr. U. Kiltz.

Ethics declarations

Interessenkonflikt

J. Braun und U. Kiltz geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

A. Radbruch, Berlin

R.E. Schmidt, Hannover

R. Straub, Regensburg

U. Wagner, Leipzig

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Braun, J., Kiltz, U. Was gibt es Neues zur Gicht?. Z Rheumatol 78, 540–549 (2019). https://doi.org/10.1007/s00393-019-0667-y

Download citation